Molecular dynamics simulations in drug discovery and pharmaceutical development

Molecular dynamics (MD) simulations have become increasingly useful in the modern drug development process. In this review, we give a broad overview of the current application possibilities of MD in drug discovery and pharmaceutical development. Starting from the target validation step of the drug d...

Full description

Saved in:
Bibliographic Details
Main Authors: Salo-Ahen, Outi M. H. (Author) , Alanko, Ida (Author) , Bhadane, Rajendra (Author) , Bonvin, Alexandre M. J. J. (Author) , Honorato, Rodrigo Vargas (Author) , Hossain, Shakhawath (Author) , Juffer, André H. (Author) , Kabedev, Aleksei (Author) , Lahtela-Kakkonen, Maija (Author) , Larsen, Anders Støttrup (Author) , Lescrinier, Eveline (Author) , Marimuthu, Parthiban (Author) , Mirza, Muhammad Usman (Author) , Mustafa, Ghulam (Author) , Nunes-Alves, Ariane (Author) , Pantsar, Tatu (Author) , Saadabadi, Atefeh (Author) , Singaravelu, Kalaimathy (Author) , Vanmeert, Michiel (Author)
Format: Article (Journal)
Language:English
Published: 2021
In: Processes
Year: 2020, Volume: 9, Issue: 1
ISSN:2227-9717
DOI:10.3390/pr9010071
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/pr9010071
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2227-9717/9/1/71
Get full text
Author Notes:Outi M. H. Salo-Ahen, Ida Alanko, Rajendra Bhadane, Alexandre M.J.J. Bonvin, Rodrigo Vargas Honorato, Shakhawath Hossain, André H. Juffer, Aleksei Kabedev, Maija Lahtela-Kakkonen, Anders Støttrup Larsen, Eveline Lescrinier, Parthiban Marimuthu, Muhammad Usman Mirza, Ghulam Mustafa, Ariane Nunes-Alves, Tatu Pantsar, Atefeh Saadabadi, Kalaimathy Singaravelu and Michiel Vanmeert

MARC

LEADER 00000caa a2200000 c 4500
001 1750870207
003 DE-627
005 20230426083824.0
007 cr uuu---uuuuu
008 210309r20212020xx |||||o 00| ||eng c
024 7 |a 10.3390/pr9010071  |2 doi 
035 |a (DE-627)1750870207 
035 |a (DE-599)KXP1750870207 
035 |a (OCoLC)1341398190 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 30  |2 sdnb 
100 1 |a Salo-Ahen, Outi M. H.  |e VerfasserIn  |0 (DE-588)1188069403  |0 (DE-627)1666994952  |4 aut 
245 1 0 |a Molecular dynamics simulations in drug discovery and pharmaceutical development  |c Outi M. H. Salo-Ahen, Ida Alanko, Rajendra Bhadane, Alexandre M.J.J. Bonvin, Rodrigo Vargas Honorato, Shakhawath Hossain, André H. Juffer, Aleksei Kabedev, Maija Lahtela-Kakkonen, Anders Støttrup Larsen, Eveline Lescrinier, Parthiban Marimuthu, Muhammad Usman Mirza, Ghulam Mustafa, Ariane Nunes-Alves, Tatu Pantsar, Atefeh Saadabadi, Kalaimathy Singaravelu and Michiel Vanmeert 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published: 30 December 2020 
500 |a Gesehen am 09.03.2021 
520 |a Molecular dynamics (MD) simulations have become increasingly useful in the modern drug development process. In this review, we give a broad overview of the current application possibilities of MD in drug discovery and pharmaceutical development. Starting from the target validation step of the drug development process, we give several examples of how MD studies can give important insights into the dynamics and function of identified drug targets such as sirtuins, RAS proteins, or intrinsically disordered proteins. The role of MD in antibody design is also reviewed. In the lead discovery and lead optimization phases, MD facilitates the evaluation of the binding energetics and kinetics of the ligand-receptor interactions, therefore guiding the choice of the best candidate molecules for further development. The importance of considering the biological lipid bilayer environment in the MD simulations of membrane proteins is also discussed, using G-protein coupled receptors and ion channels as well as the drug-metabolizing cytochrome P450 enzymes as relevant examples. Lastly, we discuss the emerging role of MD simulations in facilitating the pharmaceutical formulation development of drugs and candidate drugs. Specifically, we look at how MD can be used in studying the crystalline and amorphous solids, the stability of amorphous drug or drug-polymer formulations, and drug solubility. Moreover, since nanoparticle drug formulations are of great interest in the field of drug delivery research, different applications of nano-particle simulations are also briefly summarized using multiple recent studies as examples. In the future, the role of MD simulations in facilitating the drug development process is likely to grow substantially with the increasing computer power and advancements in the development of force fields and enhanced MD methodologies. 
534 |c 2020 
650 4 |a binding free energy 
650 4 |a computational pharmaceutics 
650 4 |a computer-aided drug design 
650 4 |a conformational ensemble 
650 4 |a drug formulations 
650 4 |a drug targets 
650 4 |a enhanced sampling methods 
650 4 |a ligand binding kinetics 
650 4 |a membrane interactions 
650 4 |a protein flexibility 
700 1 |a Alanko, Ida  |e VerfasserIn  |4 aut 
700 1 |a Bhadane, Rajendra  |e VerfasserIn  |4 aut 
700 1 |a Bonvin, Alexandre M. J. J.  |e VerfasserIn  |4 aut 
700 1 |a Honorato, Rodrigo Vargas  |e VerfasserIn  |4 aut 
700 1 |a Hossain, Shakhawath  |e VerfasserIn  |4 aut 
700 1 |a Juffer, André H.  |e VerfasserIn  |4 aut 
700 1 |a Kabedev, Aleksei  |e VerfasserIn  |4 aut 
700 1 |a Lahtela-Kakkonen, Maija  |e VerfasserIn  |4 aut 
700 1 |a Larsen, Anders Støttrup  |e VerfasserIn  |4 aut 
700 1 |a Lescrinier, Eveline  |e VerfasserIn  |4 aut 
700 1 |a Marimuthu, Parthiban  |e VerfasserIn  |4 aut 
700 1 |a Mirza, Muhammad Usman  |e VerfasserIn  |4 aut 
700 1 |a Mustafa, Ghulam  |e VerfasserIn  |0 (DE-588)1155971728  |0 (DE-627)1018525629  |0 (DE-576)501970495  |4 aut 
700 1 |a Nunes-Alves, Ariane  |e VerfasserIn  |0 (DE-588)1214207375  |0 (DE-627)1725177315  |4 aut 
700 1 |a Pantsar, Tatu  |e VerfasserIn  |4 aut 
700 1 |a Saadabadi, Atefeh  |e VerfasserIn  |4 aut 
700 1 |a Singaravelu, Kalaimathy  |e VerfasserIn  |4 aut 
700 1 |a Vanmeert, Michiel  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Processes  |d Basel : MDPI, 2013  |g 9(2021,1) Artikel-Nummer 71, 60 Seiten  |h Online-Ressource  |w (DE-627)750371439  |w (DE-600)2720994-5  |w (DE-576)384590829  |x 2227-9717  |7 nnas  |a Molecular dynamics simulations in drug discovery and pharmaceutical development 
773 1 8 |g volume:9  |g year:2021  |g number:1  |a Molecular dynamics simulations in drug discovery and pharmaceutical development 
856 4 0 |u https://doi.org/10.3390/pr9010071  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2227-9717/9/1/71  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210309 
993 |a Article 
994 |a 2021 
998 |g 1214207375  |a Nunes-Alves, Ariane  |m 1214207375:Nunes-Alves, Ariane  |p 15 
998 |g 1155971728  |a Mustafa, Ghulam  |m 1155971728:Mustafa, Ghulam  |p 14 
999 |a KXP-PPN1750870207  |e 3883191809 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Outi M. H. Salo-Ahen, Ida Alanko, Rajendra Bhadane, Alexandre M.J.J. Bonvin, Rodrigo Vargas Honorato, Shakhawath Hossain, André H. Juffer, Aleksei Kabedev, Maija Lahtela-Kakkonen, Anders Støttrup Larsen, Eveline Lescrinier, Parthiban Marimuthu, Muhammad Usman Mirza, Ghulam Mustafa, Ariane Nunes-Alves, Tatu Pantsar, Atefeh Saadabadi, Kalaimathy Singaravelu and Michiel Vanmeert"]},"person":[{"display":"Salo-Ahen, Outi M. H.","roleDisplay":"VerfasserIn","role":"aut","family":"Salo-Ahen","given":"Outi M. H."},{"display":"Alanko, Ida","roleDisplay":"VerfasserIn","role":"aut","family":"Alanko","given":"Ida"},{"role":"aut","display":"Bhadane, Rajendra","roleDisplay":"VerfasserIn","given":"Rajendra","family":"Bhadane"},{"family":"Bonvin","given":"Alexandre M. J. J.","roleDisplay":"VerfasserIn","display":"Bonvin, Alexandre M. J. J.","role":"aut"},{"given":"Rodrigo Vargas","family":"Honorato","role":"aut","roleDisplay":"VerfasserIn","display":"Honorato, Rodrigo Vargas"},{"display":"Hossain, Shakhawath","roleDisplay":"VerfasserIn","role":"aut","family":"Hossain","given":"Shakhawath"},{"role":"aut","display":"Juffer, André H.","roleDisplay":"VerfasserIn","given":"André H.","family":"Juffer"},{"family":"Kabedev","given":"Aleksei","roleDisplay":"VerfasserIn","display":"Kabedev, Aleksei","role":"aut"},{"given":"Maija","family":"Lahtela-Kakkonen","role":"aut","roleDisplay":"VerfasserIn","display":"Lahtela-Kakkonen, Maija"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Larsen, Anders Støttrup","given":"Anders Støttrup","family":"Larsen"},{"family":"Lescrinier","given":"Eveline","roleDisplay":"VerfasserIn","display":"Lescrinier, Eveline","role":"aut"},{"family":"Marimuthu","given":"Parthiban","roleDisplay":"VerfasserIn","display":"Marimuthu, Parthiban","role":"aut"},{"given":"Muhammad Usman","family":"Mirza","role":"aut","roleDisplay":"VerfasserIn","display":"Mirza, Muhammad Usman"},{"roleDisplay":"VerfasserIn","display":"Mustafa, Ghulam","role":"aut","family":"Mustafa","given":"Ghulam"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Nunes-Alves, Ariane","given":"Ariane","family":"Nunes-Alves"},{"roleDisplay":"VerfasserIn","display":"Pantsar, Tatu","role":"aut","family":"Pantsar","given":"Tatu"},{"family":"Saadabadi","given":"Atefeh","roleDisplay":"VerfasserIn","display":"Saadabadi, Atefeh","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Singaravelu, Kalaimathy","role":"aut","family":"Singaravelu","given":"Kalaimathy"},{"role":"aut","display":"Vanmeert, Michiel","roleDisplay":"VerfasserIn","given":"Michiel","family":"Vanmeert"}],"title":[{"title":"Molecular dynamics simulations in drug discovery and pharmaceutical development","title_sort":"Molecular dynamics simulations in drug discovery and pharmaceutical development"}],"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"id":{"doi":["10.3390/pr9010071"],"eki":["1750870207"]},"note":["Published: 30 December 2020","Gesehen am 09.03.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1750870207","language":["eng"],"relHost":[{"title":[{"title_sort":"Processes","title":"Processes","subtitle":"open access journal"}],"origin":[{"dateIssuedKey":"2013","publisher":"MDPI","dateIssuedDisp":"2013-","publisherPlace":"Basel"}],"id":{"eki":["750371439"],"zdb":["2720994-5"],"issn":["2227-9717"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Molecular dynamics simulations in drug discovery and pharmaceutical developmentProcesses","physDesc":[{"extent":"Online-Ressource"}],"recId":"750371439","language":["eng"],"pubHistory":["1.2013 -"],"part":{"volume":"9","text":"9(2021,1) Artikel-Nummer 71, 60 Seiten","year":"2021","issue":"1"}}]} 
SRT |a SALOAHENOUMOLECULARD2021